2024
National age-specific mortality trends for cervical and breast cancers in urban–rural areas of China from 2009 to 2021: a population-based analysis
Li M, Qi J, Ma Y, Shu W, Xiao H, Wang L, Yin P, Guo H, Vermund S, Zhou M, Hu Y. National age-specific mortality trends for cervical and breast cancers in urban–rural areas of China from 2009 to 2021: a population-based analysis. Military Medical Research 2024, 11: 55. PMID: 39138529, PMCID: PMC11323448, DOI: 10.1186/s40779-024-00561-4.Peer-Reviewed Original ResearchConceptsAverage annual percent changeUrban-rural differencesMortality trendsRural areasNational Disease Surveillance Point SystemAge-specific mortality trendsBreast cancerDisease Surveillance Points systemAge groupsCancer control programsPromote health equityMortality rate ratiosAnnual percent changeRural-urban disparitiesRural-urban differencesRural areas of ChinaNegative binomial regression modelsUrban-rural areasTemporal trendsAge-specific mortalityPopulation-based analysisMortality rateBinomial regression modelsHealth equityJoinpoint models
2023
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Filardi B, Monteiro V, Schwartzmann P, do Prado Martins V, Zucca L, Baiocchi G, Malik A, Silva J, Hahn A, Chen N, Pham K, Pérez-Then E, Miric M, Brache V, Cochon L, Larocca R, Della Rosa Mendez R, Silveira D, Pinto A, Croda J, Yildirim I, Omer S, Ko A, Vermund S, Grubaugh N, Iwasaki A, Lucas C, Initiative Y, Vogels C, Breban M, Koch T, Chaguza C, Tikhonova I, Castaldi C, Mane S, De Kumar B, Ferguson D, Kerantzas N, Peaper D, Landry M, Schulz W. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose. Science Translational Medicine 2023, 15: eade6023. PMID: 36791210, DOI: 10.1126/scitranslmed.ade6023.Peer-Reviewed Original ResearchConceptsBooster doseAntibody responseNeutralization titersVirus-specific IgG titersOlder adultsAntiviral humoral immunityPlasma antibody responsesHigh-risk populationSARS-CoV-2 spikeYears of ageAge-dependent impairmentHeterologous regimensBooster dosesBooster vaccineCoronaVac vaccineIgG titersProtective immunityHumoral immunityHumoral responseCoronaVacOmicron waveBooster strategyAge groupsEarly controlVaccine
1992
HIV and AIDS among adolescents in the United States: increasing risk in the 1990s
Bowler S, Sheon A, D'angelo L, Vermund S. HIV and AIDS among adolescents in the United States: increasing risk in the 1990s. Journal Of Adolescence 1992, 15: 345-371. PMID: 1487574, DOI: 10.1016/0140-1971(92)90069-h.Peer-Reviewed Original ResearchConceptsAcquired Immunodeficiency SyndromeHuman immunodeficiency virusHIV infectionHIV/Acquired Immunodeficiency SyndromeInjection drug equipmentYoung male homosexualsHIV risk factorsHIV seroprevalence studyAdolescent age groupHigher case ratesKey treatment issuesHigh rateHIV seroprevalenceInfected partnerImmunodeficiency syndromeImmunodeficiency virusRisk factorsSeroprevalence studyAIDS casesAIDS surveillanceHeterosexual epidemicTreatment servicesDrug useUnprotected sexAge groups
1989
Increasing Rate of Pneumonia Hospitalizations in the Bronx: A Sentinel Indicator for Human Immunodeficiency Virus
DRUCKER E, WEBBER MP, McMASTER P, VERMUND SH. Increasing Rate of Pneumonia Hospitalizations in the Bronx: A Sentinel Indicator for Human Immunodeficiency Virus. International Journal Of Epidemiology 1989, 18: 926-933. PMID: 2621030, DOI: 10.1093/ije/18.4.926.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaHuman immunodeficiency virusPneumonia hospitalizationsImmunodeficiency virusImmune disordersAge groupsDays of hospitalizationLength of stayLocal health care systemAdult AIDS casesHealth care systemPneumonia ratesHospital deathHospital admissionCarinii pneumoniaDischarge diagnosisAIDS casesHospitalizationTotal daysPneumoniaPrevalence patternsAIDS prevalenceSentinel indicatorCare systemDisease prevalence